Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
When concentrated A2M is injected into osteoarthritic joints, it halts the progression of the disease and initiates cartilage repair and regeneration
Changes may be coming The FDA, under Kennedys authority, recently removed a number of experts from the compounding advisory panel
The catch is licensing
But BPC-157 continues gaining momentum in real-world users because it simply works in places where modern rehabilitation medicines don't: slow tendon healing connective tissue recovery chronic inflammatory pain post-surgical fibrosis overuse injuries impaired vascularization gastrointestinal barrier dysfunction recovery bottlenecks in repetitive stress conditions It's quite clear that the regenerative properties of BPC-157, especially when it comes to tissue repair, have only increased the buzz around this peptide
